ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Moleculin Announces Significant Discovery in Lung Cancer Models
April 22, 2019Moleculin Announces Significant Discovery in Lung Cancer Models... -
Moleculin Announces FDA Filing for Orphan Drug Designation for Glioblastoma Drug
December 10, 2018Moleculin Biotech, Inc., a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based on license .... -
Moleculin Receives Orphan Drug Designation for Annamycin for the Treatment of Acute Myeloid Leukemia
March 23, 2017Moleculin Biotech, Inc. announced its lead candidate, Annamycin (also known as "Liposomal Annamycin"), an anthracycline, has received Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of acute myeloid leukemia (AML).
Pharma Sources Insight January 2025
